focus -WSS

focus

author：leisure time 2025-09-28 02:27:14 - browse：91181

The term “excited delirium” has been used for years by law enforcement and other first responders, including health care workers, to describe people who exhibit behavior that is considered “out of control.” This diagnosis has been applied again and again, even posthumously, as a justification for extreme, and sometimes deadly, interventions by law enforcement. It came up most recently in the trials of two police officers accused of causing the death of Elijah McClain, a Colorado man; both officers were acquitted this week.

But excited delirium is not an evidence-based medical diagnosis. The American College of Emergency Physicians recently withdrew a 2009 white paper endorsing the concept, and California has banned it as a cause of death. Other states may follow suit.

On this week’s episode, we are joined by Utsha G. Khatri, an assistant professor of emergency medicine and population health and policy at the Icahn School of Medicine at Mount Sinai, and emergency physician Brooks Walsh, who was involved with the campaign to get ACEP to withdraw the 2009 white paper. Khatri and Walsh speak about why the “excited delirium” label is both unnecessary and dangerous.

“We recognize that some patients are confused. They’re not thinking clearly they might have risk for becoming violent either toward themselves or towards other staff,” Khatri said. “It is our job not just to keep them and everyone else safe, but also to most importantly find out what is causing them to act in this way.”

You can read Khatri’s First Opinion essay on the end of “excited delirium” here.

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts.

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： The untold story of TV’s first prescription drug ad

hotspot

WSS

The public health thinking behind the CDC’s new Covid guidance

Microsoft's Peter Lee: Generative AI could help doctors be more human

Ozempic has benefits for kidney disease as well as diabetes

$1 billion proposal to grow Boston, Massachusetts biotech

Just how powerful is the placebo effect?

Excited delirium, Elijah McClain, and emergency physicians

explore

focus

knowledge

Moonlake's readout produced a cash windfall. Risks remain

Microsoft's Peter Lee: Generative AI could help doctors be more human

Bright Health sells Medicare Advantage business to Molina

Harvard's David Sinclair gets blowback over aging

As demand for Covid shots wanes, Moderna seeks its next success

Sanofi CEO defends move to abandon profit guidance, boost research

FDA approval of Sarepta Duchenne genetic therapy gives me hope

A clever new way to fix Medicaid and graduate medical education

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Medicare will require more price transparency from hospitals

hotspot

Medicare drug price negotiation continues, as pharma counteroffers

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

Pregnant women don't need prenatal multivitamins, study concludes

10 million people disenrolled from Medicaid over past six months

Biotech incubator Curie.Bio graduates its first startup

STAT Executive Editor Rick Berke on STAT's 8th birthday

Wikipedia

knowledge

hotspot

explore